David Almeida is an Ophthalmology physician affiliated with Erie VA Medical Center. OpenAlex indexes 150 publications with 1,884 citations (h-index 24).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
65 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
65 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
74.9%Antineovascularisation agents64.8%Faricimab-svoa100%Part B, office-administered≥21 patientsCorticosteroid7.9%Dexamethasone75%Prednisolone Acetate26%Part D + Part B≥46 patients+ 3 more classes in this area
Cancer & immunology
24.9%Vascular Endothelial Growth Factor Inhibitor24.9%Aflibercept100%Part B, office-administered≥144 patientsMetabolism & gastrointestinal
0.3%Anticholinergic0.3%Atropine Sulfate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 2002–2020 per NIH RePORTER. The latest:
- Psychosocial Determinants and Biological Pathway to Healthy Aging (Pathways)
Pennsylvania State University, the
FY2020$200,761T32AG049676 - Psychosocial Determinants and Biological Pathway to Healthy Aging (Pathways)
Pennsylvania State University, the
FY2019$469,262T32AG049676 - Psychosocial Determinants and Biological Pathway to Healthy Aging (Pathways)
Pennsylvania State University, the
FY2018$456,025T32AG049676
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”